Diclofenac formulations and methods of use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9827197
SERIAL NO

14534428

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods and formulations are provided for treating migraine and other acute pain episodes using diclofenac, and formulations of diclofenac that provide both rapid and sustained relief from acute pain. Methods and formulations are also provided for treating symptoms that often accompany migraine and acute pain such as photophobia, phonophobia, nausea and vomiting.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
APR APPLIED PHARMA RESEARCH S ASWISS BALER NA BALERNA TICINO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Meyer, Andreas Neuenburg, DE 162 997
Reiner, Alberto Como, IT 53 284
Reiner, Giorgio Como, IT 41 152

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 28, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00